Sanofi Consumer Healthcare India vs Nifty 50: Returns Compared
- September 2, 2026
- Posted by: Kunal Singla
- Category: Market
Sanofi Consumer Healthcare India share price Rs 4,092.00 on NSE. Sanofi Consumer Healthcare India vs Nifty 50 over 1 year: -19.61% vs -2.41%. 52-week high Rs 5,330.00, low Rs 3,975.00.
Quick Answer
Sanofi Consumer Healthcare India vs Nifty 50 shows Sanofi Consumer Healthcare India trailing the benchmark on a one-year view, with a return of -19.61% against the Nifty 50’s -2.41%. With limited comparable trading history, longer-term comparisons against the Nifty 50 are not yet meaningful for this stock. Investors comparing the two should also weigh Sanofi Consumer Healthcare India’s trading liquidity, valuation and sector context rather than relying on returns alone.
Sanofi Consumer Healthcare India vs Nifty 50 is a comparison that looks different depending on the time frame chosen. Sanofi Consumer Healthcare India trades on the NSE under the symbol SANOFICONR, and its 1M return of -9.86% compares with the Nifty 50’s -1.44% over the same period.
The Sanofi Consumer Healthcare India vs Nifty 50 comparison matters because Sanofi Consumer Healthcare India is a single stock exposed to its own sector and company-specific developments, while the Nifty 50 spreads risk across 50 large companies. This article lines up Sanofi Consumer Healthcare India share price performance against the Nifty 50 across 1 month, 3 months, 6 months, 1 year, using NSE closing data.
Click Here – Get Free Investment Predictions
Sanofi Consumer Healthcare India vs Nifty 50: Performance at a Glance
The table below sets out Sanofi Consumer Healthcare India vs Nifty 50 performance across the available time frames, measured from NSE closing prices up to 2 September 2026.
| Time Frame | Sanofi Consumer Healthcare India Return | Nifty 50 Return | Difference |
|---|---|---|---|
| 1 Month | -9.86% | -1.44% | -8.41% pp |
| 3 Months | -12.39% | +2.78% | -15.17% pp |
| 6 Months | -7.55% | -3.35% | -4.2% pp |
| 1 Year | -19.61% (Sanofi Consumer Healthcare India) | -2.41% (Nifty 50) | -17.2% pp |
On the Sanofi Consumer Healthcare India vs Nifty 50 scorecard, Sanofi Consumer Healthcare India has lagged the index over the most recent one-year window. With limited comparable trading history, longer-term comparisons against the Nifty 50 are not yet meaningful for this stock.
Check the Univest Screener for live Sanofi Consumer Healthcare India and Nifty 50 data
Why the Sanofi Consumer Healthcare India vs Nifty 50 Gap Exists
Sanofi Consumer Healthcare India’s stock can move quite differently from the Nifty 50 because it carries concentrated exposure to its own sector and business cycle, unlike the index which blends 50 companies across banking, IT, energy and consumer sectors. This is the main driver of the gap seen in the Sanofi Consumer Healthcare India vs Nifty 50 return table above.
A second factor behind the Sanofi Consumer Healthcare India vs Nifty 50 divergence is valuation and trading liquidity. Company-specific news, quarterly results and sector sentiment can move Sanofi Consumer Healthcare India’s price sharply in either direction over short periods, while the Nifty 50’s return reflects the blended earnings trajectory of its constituents and is far less exposed to any single stock’s swings.
Download the Univest iOS App or Univest Android App to track Sanofi Consumer Healthcare India and Nifty 50 live on the go.
Sanofi Consumer Healthcare India vs Nifty 50: Has Sanofi Consumer Healthcare India Beaten the Benchmark?
Sanofi Consumer Healthcare India has not kept pace with the Nifty 50 over the past year, posting a return of -19.61% against the index’s -2.41% over the same period.
Risks of the Sanofi Consumer Healthcare India vs Nifty 50 Comparison
Reading too much into a Sanofi Consumer Healthcare India vs Nifty 50 comparison has real limitations that investors should weigh before drawing conclusions. Sanofi Consumer Healthcare India carries concentrated business and sector risk that a diversified index does not, and its trading volumes and price swings can differ meaningfully from the Nifty 50’s more liquid, blended profile. A stock’s 52-week range of Rs 3,975.00 to Rs 5,330.00 also shows the kind of volatility that a single-stock investment carries relative to a broad index.
Conclusion
Sanofi Consumer Healthcare India vs Nifty 50 highlights how a single stock’s return path can differ from a diversified benchmark over different time horizons. Investors weighing the Sanofi Consumer Healthcare India vs Nifty 50 record should factor in Sanofi Consumer Healthcare India’s volatility, liquidity and sector concentration alongside its return history, and consult a SEBI-registered advisor before making an allocation decision.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Has Sanofi Consumer Healthcare India outperformed the Nifty 50 in the last year?
Ans. No. Sanofi Consumer Healthcare India returned -19.61% over the past year while the Nifty 50 returned -2.41% over the same period, based on NSE closing prices to 2 September 2026.
What is the Sanofi Consumer Healthcare India share price today compared to Nifty 50?
Ans. Sanofi Consumer Healthcare India share price stood at Rs 4,092.00 on NSE, while the Nifty 50 traded at 24,031.60 based on the same closing data window.
What is the 52-week high and low of Sanofi Consumer Healthcare India?
Ans. Sanofi Consumer Healthcare India’s 52-week high is Rs 5,330.00 and its 52-week low is Rs 3,975.00, based on NSE data.
Why does Sanofi Consumer Healthcare India show bigger price swings than the Nifty 50?
Ans. Sanofi Consumer Healthcare India carries concentrated exposure to its own sector and business cycle, while the Nifty 50 spreads risk across 50 large companies, so company-specific news moves Sanofi Consumer Healthcare India’s price more sharply than the diversified index, a key reason the Sanofi Consumer Healthcare India vs Nifty 50 return gap varies across time frames.
Is Sanofi Consumer Healthcare India a good long-term investment compared to a Nifty 50 index fund?
Ans. Sanofi Consumer Healthcare India’s suitability depends on an investor’s risk appetite, since single-stock exposure carries higher concentration risk than a diversified Nifty 50 index fund; long-term investors should weigh the Sanofi Consumer Healthcare India vs Nifty 50 return history alongside the company’s fundamentals and consult a SEBI-registered advisor.
